Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Miller who wrote (3375)	6/29/1999 10:11:00 PM
From: LLCF	Read Replies (2) of 10280

<At the annual meeting, Barberich indicated J&J had looked at buying the company, but elected to pass until Sepracor is profitable. They want any purchase to be accretive to earnings. J&J indicated they would look at them at a later date.> Just classic isn't it? No wonder biotech is so undervalued... the geniuses at 'big pharma' would rather pay $400 a share in a couple years than $100 now. 'We don't want to do anything that even one brain dead analyst or paranoid geriatric shareholder might construe as NOT warm and fuzzy' said Big Pharma CEO I. Mediocre. 'I'm up for options next year, and retirement in 2 years' he was heard to say after the press conference. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next